Call 650-263-7636 / Email

Endothelial Dysfunction in Long-COVID

Similar articles
  • Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, Bahloul A, Kallel N, Moussa N, Touil I, Ghrab A, Elghoul J, Meddeb Z, Thabet Y, Kammoun S, Bouslama K, Milouchi S, Abdessalem S, Abid L. Front Cardiovasc Med. 2021 Nov 30;8:745758.
References
  1. Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626–631. – PMC – PubMed
  2. Adeloye D., Elneima O., Daines L., et al. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease. Lancet Respir Med. 2021;9:1467–1478. – PMC – PubMed
  3. Trimarco V., Izzo R., Mone P., Trimarco B., Santulli G. Targeting endothelial dysfunction and oxidative stress in Long-COVID. Pharmacol Res. 2022;184 – PMC – PubMed
  4. Izzo R., Trimarco V., Mone P., et al. Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey. Pharmacol Res. 2022;183 – PMC – PubMed
  5. Gambardella J., Khondkar W., Morelli M.B., Wang X., Santulli G., Trimarco V. Arginine and Endothelial Function. Biomedicines. 2020;8:277. – PMC – PubMed
  6. Morelli M.B., Gambardella J., Castellanos V., Trimarco V., Santulli G. Vitamin C and Cardiovascular Disease: An Update. Antioxidants (Basel) 2020;9:1227. – PMC – PubMed
Scientific Updates
Sponsored by Endothelix Inc.

LATEST SCIENTIFIC UPDATES